Thanh (tomas) Van

I lead clinical operations at Viking Therapeutics, managing global Phase I–III trials across oncology, metabolic diseases, and cell and gene therapy. I oversee the full trial lifecycle from IND submissions through regulatory readouts, specializing in First-in-Human studies and pivotal trials in areas like metastatic breast cancer, diabetes, and obesity. With 14 years across academic, pharma, and biotech settings, I focus on hitting timelines, managing cross-functional teams, and ensuring regulatory readiness under GCP and ICH standards.

Ask me about clinical trial design, regulatory submissions, managing global trials, and leading clinical operations teams.